Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Interpharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (57)
Cancellation by sponsor (14)
Prescription medicine registration (7)
Cancellation or suspension (4)
Australian public assessment report (AusPar) (1)
Prescription medicine decision summary (1)

Date

2025 (9)
2024 (4)
2023 (10)
2022 (21)
2021 (4)
2020 (9)
2019 (9)
2018 (5)
2017 (3)
2016 (2)
2015 (6)
2013 (1)
2012 (1)

Search

Sponsor content

84 result(s) found, displaying 41 to 50

Interpharma Pty Ltd - IIrrigation fluid, medical/surgical procedure Cancelled under Section 41GL(d) of the Act

5 September 2022

Cancellation by sponsor

Requested by Interpharma Pty Ltd
ESMOLOL NORIDEM (Interpharma Pty Ltd)

27 August 2022

Prescription medicine registration

Active ingredients: Esmolol hydrochloride.
Interpharma Pty Ltd - Hypodermic needle, single-use, sterile (351454)

9 December 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Interpharma Pty Ltd - Hypodermic needle, single-use, sterile.
LIDOCAINE NORIDEM (Interpharma Pty Ltd)

11 July 2022

Prescription medicine registration

Active ingredients: lidocaine (lignocaine) hydrochloride monohydrate.
WATER FOR INJECTIONS water for injections 20 mL ampoule Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Interpharma Pty Ltd
SODIUM CHLORIDE FOR INJECTION 0.9% w/v sodium chloride for injection 20 mL ampoule Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Interpharma Pty Ltd
SODIUM CHLORIDE FOR INJECTION 0.9% w/v sodium chloride for injection 5 mL ampoule Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Interpharma Pty Ltd
WATER FOR INJECTIONS water for injections 5 mL ampoule Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Interpharma Pty Ltd
CABAZITAXEL EVER PHARMA cabazitaxel 60 mg/6 mL concentrated solution for injection vial (321013)

27 October 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CABAZITAXEL EVER PHARMA cabazitaxel 60 mg/6 mL concentrated solution for injection vial.
CABAZITAXEL EVER PHARMA cabazitaxel 50 mg/5 mL concentrated solution for injection vial (320982)

27 October 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CABAZITAXEL EVER PHARMA cabazitaxel 50 mg/5 mL concentrated solution for injection vial.

Pages

First page
Previous page
Page 1
Page 2
Page 3
Page 4
Current page 5
Page 6
Page 7
Page 8
Page 9
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.